wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37028648-21E5F76A-1EBD-47E9-A5AF-4E51D0FFEA28
Q37028648-21E5F76A-1EBD-47E9-A5AF-4E51D0FFEA28
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37028648-21E5F76A-1EBD-47E9-A5AF-4E51D0FFEA28
Phase 3 study of dasatinib 140 mg once daily versus 70 mg twice daily in patients with chronic myeloid leukemia in accelerated phase resistant or intolerant to imatinib: 15-month median follow-up.
P2860
Q37028648-21E5F76A-1EBD-47E9-A5AF-4E51D0FFEA28
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37028648-21E5F76A-1EBD-47E9-A5AF-4E51D0FFEA28
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
aecb509c0569feb7ef3c1c91ce076d7320224041
P2860
Metabolism and disposition of dasatinib after oral administration to humans.